Skip to content

Panel 30 RESP_A2

by MEDIWISS ANALYTIC GmbH Gesellschaft für angewandte in-vitro Analytik Germany EUDAMED

Ref 0371

EMDN W01020205

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-04251342603718 Basic UDI-DIDate28 Jan 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
AllergyScreen®/AlleisaScreen®
Model / Reference
0371
Primary DI / UDI-DI
04251342603718
Basic UDI-DI
B-04251342603718
EMDN Code
W01020205 Immunoglobulin e - screen
Device Class
Class IVD General
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
DE-MF-000004992

Other devices from MEDIWISS ANALYTIC GmbH Gesellschaft für angewandte in-vitro Analytik

See all devices from MEDIWISS ANALYTIC GmbH Gesellschaft für angewandte in-vitro Analytik →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Professional Testing
Other properties (8)
  • Sterile: No
  • Human Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED aafde1a1-f403-4d86-b935-1c2092ebabc5 61 fields · synced 24 Oct 2026